APA (7th ed.) Citation

Fernandez‐Mercado, M., Pellagatti, A., Di Genua, C., Larrayoz, M. J., Winkelmann, N., Aranaz, P., . . . Boultwood, J. (2013). Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression. British Journal of Haematology, 163(2), 235. https://doi.org/10.1111/bjh.12491

Chicago Style (17th ed.) Citation

Fernandez‐Mercado, Marta, et al. "Mutations in SETBP1 Are Recurrent in Myelodysplastic Syndromes and Often Coexist with Cytogenetic Markers Associated with Disease Progression." British Journal of Haematology 163, no. 2 (2013): 235. https://doi.org/10.1111/bjh.12491.

MLA (9th ed.) Citation

Fernandez‐Mercado, Marta, et al. "Mutations in SETBP1 Are Recurrent in Myelodysplastic Syndromes and Often Coexist with Cytogenetic Markers Associated with Disease Progression." British Journal of Haematology, vol. 163, no. 2, 2013, p. 235, https://doi.org/10.1111/bjh.12491.